CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale EVP and Chief Medical Officer sold 5,000 shares at $109.09 ($545,450)
- 4 Grant or award SVP, Chief Accounting Officer acquired 1,500 shares (grant or award)
- 4 Open-market sale SVP, Controller and PAO sold 3,000 shares at $120.69 ($362,070)
- 4 Open-market sale CBO & EVP sold 4,572 shares at $138.17 ($631,713)
- 4 Open-market sale Pinion John Richard sold 6,198 shares at $138.17 ($856,378)
- 4 Open-market sale EVP and General Counsel sold 3,970 shares at $138.17 ($548,535)
- 4 Open-market sale SVP, Controller and PAO sold 732 shares at $138.17 ($101,140)
- 4 Open-market sale EVP & Chief Commercial Officer sold 3,177 shares at an average $138.17 ($438,959)
- 4 Open-market sale EVP & Chief Tech Ops Officer sold 4,255 shares at $138.18 ($587,956)
- 4 Grant or award CFO & Executive Vice President acquired 5,500 shares (grant or award)
- 4 Open-market sale EVP and Chief Medical Officer sold 4,543 shares at $138.18 ($627,752)
- 4 Open-market sale President & CEO sold 30,000 shares at $141.80 ($4,254,000)
- 4 Open-market sale Director sold 7,500 shares at $149.01 ($1,117,575)
- 4 Open-market sale EVP & Chief Commercial Officer sold 2,516 shares at $74.69 ($187,920)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale EVP and Chief Medical Officer sold 2,243 shares at $140.36 ($314,827)
- 4 Open-market sale EVP and Chief Medical Officer sold 25,000 shares at $139.18 ($3,479,500)
- 4 Open-market sale SVP, Controller and PAO sold 4,000 shares at $140.65 ($562,600)
Page 11 of 32 · 627 filings